Anti-human CCL2 mAb (MTBH9), biotin
Anti-human CCL2 mAb (MTBH9), biotin
In stock
Delivery 4-9 business days
Shipping $0
Complementary products
Complementary products
Documents
Non-human primate cross-reactivity guide
The systems reactive with NHPs are either based on cross-reactive human kits or specifically developed monkey kits (NHP).
Cross-reactivity verification tests have been performed in ELISpot and/or ELISA by Mabtech and/or by others. Evaluations of assays with less solid evidence of cross-reactivity are shown as symbols within parentheses.
ApoA1 | |||||||||
ApoB | |||||||||
ApoE (NHP) | |||||||||
ApoE | |||||||||
ApoH | |||||||||
CCL2 (MCP-1) | |||||||||
CCL4 (MIP-1β) | ( ) | ( ) | ( ) | ( ) | ( ) | ||||
CCL22 (MDC) | ( ) | ( ) | ( ) | ( ) | ( ) | ||||
CD25 | |||||||||
GM-CSF | ( ) | ( ) | |||||||
Granzyme A | |||||||||
Granzyme B (NHP) | |||||||||
Granzyme B | |||||||||
IFN-α2 | |||||||||
IFN-α pan | ( ) | ||||||||
IFN-γ (NHP) | |||||||||
IFN-γ | ( ) | ||||||||
IgA (NHP) | |||||||||
IgA | |||||||||
IgG | |||||||||
IgM | |||||||||
INS | |||||||||
IL-1α | |||||||||
IL-1β | |||||||||
IL-2 (NHP) | |||||||||
IL-3 | |||||||||
IL-4 | ( ) | ( ) | ( ) | ( ) | |||||
IL-5 | ( ) | ( ) | ( ) | ||||||
IL-6 | ( ) | ( ) | ( ) | ||||||
IL-8 (NHP) | |||||||||
IL-8 (ELISA) | |||||||||
IL-8 (ELISpot) | |||||||||
IL-10 (NHP) | |||||||||
IL-10 | |||||||||
IL-12/-23 (p40) | |||||||||
IL-12 (p70) | |||||||||
IL-13 (NHP) | ( ) | ( ) | ( ) | ||||||
IL-13 | |||||||||
IL-17A (NHP) | ( ) | ( ) | |||||||
IL-17A | |||||||||
IL-17F | |||||||||
IL-17A/F | |||||||||
IL-21 | |||||||||
IL-22 | |||||||||
IL-23 | |||||||||
IL-27 | |||||||||
IL-31 | |||||||||
IP-10 | |||||||||
Perforin | ( ) | ||||||||
TGF-β1 (latent) | |||||||||
TNF-α (NHP) | ( ) | ( ) | ( ) | ( ) | ( ) | ||||
TNF-α | |||||||||
CD3, mAb CD3-1 | |||||||||
CD3, mAb CD3-2 | |||||||||
CD28, mAb CD28-A | |||||||||
IFN-γ mAb 1-D1K | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | |||
IL-2 mAb MT8G10 | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ||
IL-4 mAb IL4-3 | ( ) | ||||||||
IL-17A mAb MT504 | |||||||||
Perforin mAb Pf-344 | |||||||||
TNF-α mAb MT15B15 | |||||||||
IgG1 mAb MTG1218 | |||||||||
IgG1 mAb MT1939 | |||||||||
IgG2 mAb H6200 | |||||||||
IgG2 mAb MTG211E | |||||||||
IgG3 mAb MTG34 | |||||||||
IgG4 mAb MTG42 | |||||||||
IFN-γ mAb MT111W | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) |
TNF-α mAb MT15B15 | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) | ( ) |
Symbol keys:
Verified by Mabtech and/or by others. Tests performed in ELISpot and/or ELISA.
- good
- poor
- no
Based on reports from others or by analysis using recombinant proteins.
- ( ) good
- ( ) poor
- ( ) no
Specifically developed monkey kits are marked with (NHP).
Blank boxesRepresent cross-reactivities not evaluated.
* Comprises several species. Cross-reactivity may have to be verified on a species basis.
Product highlights
Publications (?)
Analyte information
CCL2 (MCP-1)
Analyte description | Chemokine ligand 2 (CCL2), also called monocyte chemoattractant protein-1 (MCP-1) and JE, belongs to the CC chemokine family. CCL2 is secreted by a wide array of cells including monocytes, macrophages, dendritic cells, endothelial cells, astrocytes, and osteoblasts. In addition to its chemotactic properties, CCL2 is involved in processes of degranulation, upregulation of receptors, cell survival, and secretion of cytokines. Its presence in multiple tissues has been linked to various diseases such as Alzheimer's, diabetes, tuberculosis, osteoporosis, and cancer where CCL2 plays a role in tumor microenvironment. |
Alternative names | C-C motif chemokine 2, Chemoattractant Protein 1, MCP-1, MCP1, HC11, GDCF-2, HSMCR30, MCAF, SCYA2, SMC-CF |
Cell type | Monocyte/MΦ |
Gene ID | 6347 |